摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

(1S,6R,8R,9R)-8,9-dihydroxy-8,9-O-isopropylidene-2,7-dioxabicyclo[3.4.0]non-4-ene | 226919-75-1

中文名称
——
中文别名
——
英文名称
(1S,6R,8R,9R)-8,9-dihydroxy-8,9-O-isopropylidene-2,7-dioxabicyclo[3.4.0]non-4-ene
英文别名
(1S,2R,6R,8R)-4,4-dimethyl-3,5,7,12-tetraoxatricyclo[6.4.0.02,6]dodec-9-ene
(1S,6R,8R,9R)-8,9-dihydroxy-8,9-O-isopropylidene-2,7-dioxabicyclo[3.4.0]non-4-ene化学式
CAS
226919-75-1
化学式
C10H14O4
mdl
——
分子量
198.219
InChiKey
XFNVOIOMPJFKIV-BZNPZCIMSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    0.5
  • 重原子数:
    14
  • 可旋转键数:
    0
  • 环数:
    3.0
  • sp3杂化的碳原子比例:
    0.8
  • 拓扑面积:
    36.9
  • 氢给体数:
    0
  • 氢受体数:
    4

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

点击查看最新优质反应信息

文献信息

  • Chiron Approach to Formal Synthesis of 8,9-dideoxyneodysiherbaine (MSVIII-19)
    作者:Alma Sanchez-Eleuterio、Virginia M. Mastranzo、Leticia Quintero、Fernando Sartillo-Piscil
    DOI:10.2174/1570178614666170307091943
    日期:2017.6.8
    Background: The synthesis of biologically active model compounds represents a valuable tool for medicinal chemistry. In this regard, the synthesis of MSVII-19, a structurally simplified model compound of Dysiherbaine, developed by the group of Sasaki, was synthesized with the intention of preparing a powerful agonist or antagonist of glutamate receptor. Therefore, the synthesis of an advanced intermediate in the Sasaki’s synthesis of MSVIII-19 is reported. Methods: Taking advantage of the furanose ring of the diacetone-D-glucose (DAG), the cis-fused hexahydrofuro[3,2-b]pyran ring system of the title compound was constructed by featuring two protocols: SHOWO (sequential hydrolysis-oxidation-Wittig olefination) and RCM (ring closing metathesis). Then, by applying a combined allylation at the anomeric position and a Pd-catalyzed double bond isomerization reaction, the methyl ester group in 1b was installed. Results: The synthesis of an advanced intermediate of MSVIII-19 involves three key procedures: a) SHOWO (sequential hydrolysis-oxidation-Wittig olefination) protocol; b) RCM (ring closing metathesis) reaction; y c) the nucleophilic substitution at the anomeric position. Additionally, with the use of a cheaper starting material (DAG) than that used in the previous synthesis (tri-O-acetyl-D-glucal). The current synthesis is truly competitive with that reported by the Sasaki group. Conclusion: A concise formal total synthesis of the advanced intermediate of MSVIII-19 was achieved. (Current synthesis: 14 steps; previous synthesis 20 steps).
    背景:生物活性模型化合物的合成是药物化学中的一项重要工具。在这方面,由佐佐木团队开发的结构简化的Dysiherbaine模型化合物MSVIII-19的合成旨在制备强效的谷氨酸受体激动剂或拮抗剂。因此,报告了佐佐木合成MSVIII-19中一个高级中间体的合成。 方法:利用二乙酮-D-葡萄糖(DAG)的呋喃环,通过两个步骤构建了标题化合物的顺式融合六氢呋喃[3,2-b]吡喃环系统:SHOWO(顺序水解-氧化-Wittig烯化)和RCM(环闭合烯烃交换反应)。然后,通过在异头位置应用联合烯丙基化和Pd催化的双键异构化反应,以安装1b中的甲基酯基团。 结果:MSVIII-19高级中间体的合成涉及三个关键程序:a) SHOWO(顺序水解-氧化-Wittig烯化)协议;b) RCM(环闭合烯烃交换)反应;c) 在异头位置的亲核取代。此外,使用了比先前合成中使用的起始材料(tri-O-乙酰-D-葡萄糖醛)更便宜的起始物质(DAG)。目前的合成与佐佐木团队报告的合成相比,具有较强的竞争力。 结论:成功实现了MSVIII-19高级中间体的简洁正式总合成。(当前合成:14步;先前合成:20步)。
  • Sequential Ring-Closing Metathesis and Nitrone Cycloaddition on Glucose-Derived Substrates:  A Divergent Approach to Analogues of Spiroannulated Carbanucleosides and Conformationally Locked Nucleosides
    作者:Sk. Sahabuddin、Ashim Roy、Michael G. B. Drew、Biswajit Gopal Roy、Basudeb Achari、Sukhendu B. Mandal
    DOI:10.1021/jo0606554
    日期:2006.8.1
    6-di-O-isopropylidene-α-d-allofuranose was judiciously manipulated for preparing suitable synthons, which could be converted to a variety of isoxazolidino-spirocycles and -tricycles through the application of ring-closing metathesis (RCM) and intramolecular nitrone cycloaddition (INC) reactions. Cleavage of the isoxazolidine rings of some of these derivatives by tranfer hydrogenolysis followed by coupling
    碳水化合物衍生的底物3- C-烯丙基-1,2:5,6-二-O-异亚丙基-α- d明智地操纵了-呋喃喃糖以制备合适的合成子,通过应用闭环复分解(RCM)和分子内硝酮环加成(INC)反应可将其合成为各种异恶唑烷-螺环和-三环。通过转移氢解裂解这些衍生物中的一些异恶唑烷环,然后将生成的氨基官能团与5-氨基-4,6-二氯嘧啶偶联,提供了相应的氯嘧啶核苷,它们被加工成螺环化的碳核苷并构象锁定了双环[2.2。]。 1]庚烷/氧杂双环[3.2.1]辛烷核苷。但是,使用较高的温度环化一个嘧啶嘧啶,导致二甲氨基嘌呤类似物成为唯一产物,
  • Haque, Azizul; Panda, Jagannath; Ghosh, Subrata, Indian Journal of Chemistry - Section B Organic and Medicinal Chemistry, 1999, vol. 38, # 1, p. 8 - 9
    作者:Haque, Azizul、Panda, Jagannath、Ghosh, Subrata
    DOI:——
    日期:——
  • A convenient route to cis- and trans-fused bicyclic ethers by ruthenium mediated ring-closing metathesis of diene and enyne carbohydrate derivatives
    作者:Michiel A. Leeuwenburgh、Camiel Kulker、Howard I. Duynstee、Herman S. Overkleeft、Gijsbert A. van der Marel、Jacques H. van Boom
    DOI:10.1016/s0040-4020(99)00296-3
    日期:1999.7
    A general approach towards the construction of highly functionalised pyranopyran and pyranofuran systems via Grubbs [Ru] catalysed ring-closing metatheses of neighbouring vinyl-O-allyl and vinyl-O-propargyl functions on monosaccharide scaffolds is described. (C) 1999 Elsevier Science Ltd. All rights reserved.
  • Synthesis of Novel Pyran <font>β</font>-Amino Acid and 5,6-Dihydro-2H-pyran <font>β</font>-aminoxy Acid from Carbohydrate Derivatives
    作者:Gattu Sridhar、Marumamula Hanumaiah、Gangavaram V. M. Sharma
    DOI:10.1080/00397911.2015.1043018
    日期:2015.8.3
    Abstract Synthesis of two new amino acids, containing pyran rings, is reported from carbohydrate derivatives. The cis-3-amino-pyran-2-carboxylic acid (cis-APyC) was prepared from (R)-glyceraldehyde derivative, using nucleophilic substitution reaction for pyran ring formation. Similarly, the trans-3-aminoxy-5,6-dihydro-2H-pyran-2-carboxylic acid (trans-AmPyC) was prepared from diacetone glucose (DAG)
    摘要 报道了从碳水化合物衍生物合成两种含有吡喃环的新氨基酸。顺-3-氨基-吡喃-2-羧酸(cis-APyC)由(R)-甘油醛衍生物制备,使用亲核取代反应形成吡喃环。类似地,反式-3-氨氧基-5,6-二氢-2H-吡喃-2-羧酸(反式-AmPyC)由双丙酮葡萄糖(DAG)制备,使用闭环复分解(RCM)反应形成环。图形概要
查看更多

同类化合物

马桑宁内酯 苦毒浆果[木防已属] 苦亭 艾瑞布林中间体 艾瑞布林 甲磺酸艾日布林 木防己苦毒宁 全内酯 二氢苦毒宁 6-甲基-4-氧代-4H-呋喃并[3,2-c]吡喃-3-甲酰氯 6-(4-羟基苯基)-2,3,3-三甲基-2H-呋喃并[5,4-b]吡喃-4-酮 4H-呋喃并[2,3-c]吡喃基莫匹罗星钠 3-甲基2H-呋喃并[2,3-c]吡喃-2-酮 3,5-二甲基2H-呋喃并[2,3-c]吡喃-2-酮 2H-呋喃并[2,3-c]吡喃-2-酮 2-[(1E,3E)-己-1,3-二烯基]-2,6-二甲基-5,6-二氢呋喃并[5,4-b]吡喃-3,4-二酮 (3aS,5S,6R,9E,14R,15R,15aR)-2,3,3a,4,5,6,7,8,11,12,13,14,15,15alpha-十四氢-6,10,14-三甲基-3-亚甲基-2-氧代-5,15-环氧环十四烷并[b]呋喃-6-醇乙酸酯 (3aR,4S,7aR)-4-羟基-3,3a,4,7a-四氢呋喃并[5,4-b]吡喃-2-酮 5-hydroxymethyl-3-methyl-2H-furo[2,3-c]pyran-2-one 5-fluoromethyl-2H-furo[2,3-c]pyran-2-one 5-chloromethyl-2H-furo[2,3-c]pyran-2-one 10,11-Anhydro-5-deoxy-1,2-O-isopropylidene-9-O-(methoxymethyl)-β-L-xylo-L-ido-7-undeculofuranose-(1,4)-pyranose-(7,3) 3,7-dimethyl-2H-furo[2,3-c]pyran-2-one 4R-(3αβ,3aβ,4β,5α,6β,7aβ)hexahydro-2,2-dimethyl-4,5-bis(phenylmethoxy)-6-[(phenylmethoxy)methyl]4H-furo[2,3-b]pyran-3-ol 10,10-dimethyl-5-(methylsulfanyl)-10,11-dihydro-8H-pyrano[4',3':4,5]furo[3,2-e]tetrazolo[1,5-c]pyrimidine (R)-3-((2R,3R,5aR,7R,9aS)-3-hydroxyhexahydro-2H-2,5a-methanopyrano[3,2-e][1,4]dioxepin-7-yl)-2-methylpropanenitrile 13-methyl-8,10,12-trioxapentacyclo[5.5.2.02,6.O3,11.05,9]-13-tetradecene 2,3,4,4a,7,8-Hexahydro-6H-2-(acetoxymethyl)-3,4-diacetoxy-1,9-dioxacyclohexainden-5-one 2,3,4,4a,7,8-Hexahydro-6H-2-methoxy-1,9-dioxacyclohexainden-5-one (-)-3a-methyl-3a,4-dihydro-1H,3H-furo[3,4-c]pyran-6,6,7-tricarboxylic acid 6,6-diethyl ester 7-methyl ester (+)-8-epi-altholactone 4-(perfluorophenyl)-3-phenylhexahydro-1H-furo[3,4-c]pyran [(2R,11S,12R,14R,15R,17R,19S)-19-tert-butyldiphenylsiloxymethyl-15-methyl-13,18-dioxadispiro(2H-3,6-dihydropyran-6,5'-oxolane-2',3''-bicyclo[4.3.0]nonane)-2-yl]phenylmethoxymethane (3aS,5S,9bS)-5-methyl-3,3a-dihydro-5H-furo[3,2-c]isochromene-2,6,9-(9bH)-trione (3aR,5R,7aR)-5-(2-hydroxypropan-2-yl)-7a-methylhexahydro-2H-furo[3,2-b]pyran-2-one 2,2,3b-trimethyl-7-vinyl-3a,5,7a,8a-tetrahydro-3bH-1,3,4,8-tetracyclopenta[a]indene ethyl 4-oxo-3-phenyl-3,3a,4,6-tetrahydro-1H-furo[3,4-c]pyran-3a-carboxylate methyl (2R,2aR,4aS,7aS,7bS)-2-methoxy-6-methyl-4-oxo-5-pentyl-2a,4,4a,7b-tetrahydro-2H-1,3,7-trioxacyclopenta[cd]indene-7a-carboxylate 4-nonyl-3-phenylhexahydro-1H-furo[3,4-c]pyran 3'-(4-methoxyphenyl)-7a'-methyl-4'H,6'H-spiro[cyclohexane-1,5'-furo[2,3-b]pyran]-2'(7a'H)-one 3',7a'-dimethyl-4'H,6'H-spiro[cyclohexane-1,5'-furo[2,3-b]pyran]-2'(7a'H)-one 2-(methylsulfanyl)-5,6-dihydro-4H-furo[2,3-b]pyran 1,1-(3-dimethylamino-3-phenylpentamethylen)-3,4-dihydro-1H-2,9-dioxafluoren 7-cyclopropyl-4,5,7,7a-tetrahydro-furo[2,3-c]pyran-2-one 7-cyclopropyl-3-phenyl-4,5,7,7a-tetrahydro-furo[2,3-c]pyran-2-one 7-cyclopropyl-3-phenyl-4,5,7,7a-tetrahydro-furo[2,3-c]pyran-2-one (4'R)-6-O-(4-cyanophenyl)-1,2,3,4-tetradeoxy-4'-(2,2,3,3,4,4,5,5,6,6,7,7,8,8,9,9,9-heptadecafluorononyl)-2',3',4',5'-tetrahydro-α-D-erythro-hexopyranoso[1,2-b]furan 2,2,3,6-tetramethyl-2,3-dihydro-4H-furo[2,3-b]pyran-4-one (1aR,4aS,5R)-7-carboethoxy-5-methylethyl-tetrahydrofurano[2,3-b]3,4-dihydro-2H-pyran (3aS,4S,7aR)-ethyl 4-methyl-3,3a,4,7a-tetrahydro-2H-furo[2,3-b]pyran-6-carboxylate